The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Accelerator ™ Drug Development: Integrated governance drives execution across global clinical research program
Case study
Managing large-scale clinical research programs across multiple vendors, geographies, sites, and timelines is a major challenge. When internal systems and resources are fragmented, the complexity and risk increase significantly. Delays, inefficiencies, and misalignment can jeopardize enrollment targets and overall program success—especially for companies managing concurrent development programs, multiple providers, and aggressive milestones.
One biopharma customer faced these challenges firsthand while running a global clinical research program spanning more than 450 sites and 800 patients, with studies at various stages of start-up and enrollment. Our latest case study highlights how they leveraged Thermo Fisher Scientific’s Accelerator™ Drug Development to regain control and deliver results through our single-vendor model, which provides integrated services and centralized oversight.
Download the case study to learn more.
